Aneurysmal subarachnoid hemorrhage (SAH) affects six to nine people per 100,000 per
year, has a 35% mortality, and leaves many with lasting disabilities, often related to cognitive …

Delayed cerebral ischemia is a major predictor of poor outcomes in patients who suffer
subarachnoid hemorrhage. Treatment options are limited and often ineffective despite many …

Background The neurointensive care management of patients with aneurysmal
subarachnoid hemorrhage (aSAH) is one of the most critical components contributing to …

Abstract Magnesium (Mg 2+) is an essential ion to the human body, playing an instrumental
role in supporting and sustaining health and life. As the second most abundant intracellular …

Magnesium is well known for its diverse actions within the human body. From a neurological
standpoint, magnesium plays an essential role in nerve transmission and neuromuscular …

Background: Intracranial aneurysm with and without subarachnoid haemorrhage (SAH) is a
relevant health problem: The overall incidence is about 9 per 100,000 with a wide range, in …

Subarachnoid haemorrhage (SAH) causes early brain injury (EBI) that is mediated by effects
of transient cerebral ischaemia during bleeding plus effects of the subarachnoid blood …

For patients who survive the initial bleeding event of a ruptured brain aneurysm, delayed
cerebral ischemia (DCI) is one of the most important causes of mortality and poor …

This is the fourth edition of the UK National clinical guideline for stroke. It is an integral part
of the broader goal of the Intercollegiate Stroke Working Party to improve the care of people …

Aneurysmal subarachnoid hemorrhage (SAH) is a worldwide health burden with high fatality
and permanent disability rates. The overall prognosis depends on the volume of the initial …